At the news
? NEUTRALIMPACT 2/10 144 filed Jun 16, 2026 at 19:58 ET
Board member Shehnaaz Suliman (ultragenyx CFO) filed intent to sell 5,723 shares of TXG Class A common stock worth approximately $184,395, executed through JP Morgan. Shares were acquired from RSU vesting over 2021-2024. The proposed sale is small relative to market cap and Suliman's likely holdings, and follows a pattern of insider selling at 10x Genomics.
- Filer: Shehnaaz Suliman, board member and CFO of ultragenyx (not TXG employee)
- Proposed sale: 5,723 shares of Class A common stock
- Estimated value: $184,395.06 (based on ~$32.23/sh)
- Broker: JP Morgan Securities LLC
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access